Department of Radiation Oncology, Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA.
Am J Clin Oncol. 2013 Feb;36(1):38-43. doi: 10.1097/COC.0b013e3182354bbb.
Primary pancreatic lymphoma (PPL) is a rare disease, accounting for only 0.5% of all pancreatic masses. A paucity of literature exists on the epidemiology and outcomes of PPL. Here, we present a series of 523 cases of PPL obtained from the Surveillance, Epidemiology, and End Results database.
Patients diagnosed with a PPL from 1973 to 2007 were identified. Data on patient and tumor characteristics as well as initial treatment with surgery or radiation were extracted. Survival rates were calculated using the Kaplan-Meier method. A multivariate analysis was performed to determine independent prognostic factors predicting mortality hazard ratios using Cox proportional hazards modeling.
Fifty-eight percent of patients identified were male. The median age range at diagnosis was 65 to 69 years. The most common histologic subtype in the present series was diffuse large B-cell lymphoma, which accounted for 56% of all patients. The 5-year overall survival for the group was 45%. Multivariate analysis suggests that age more than 60 years at diagnosis, race of "other" (compared with "white"), and marital status of single or widowed were predictive of increased all-cause mortality (P<0.05).
This represents the largest published series of patients with PPL. Age more than 60 years, female sex, and marital status of married were identified as independent prognostic factors predicting for decreased all-cause mortality.
原发性胰腺淋巴瘤(PPL)是一种罕见疾病,仅占所有胰腺肿块的 0.5%。关于 PPL 的流行病学和结果的文献很少。在这里,我们从监测、流行病学和最终结果数据库中展示了一系列 523 例 PPL 病例。
从 1973 年到 2007 年,确定了诊断为 PPL 的患者。提取了有关患者和肿瘤特征以及手术或放疗初始治疗的数据。使用 Kaplan-Meier 方法计算生存率。使用 Cox 比例风险模型进行多变量分析,以确定预测死亡率风险比的独立预后因素。
确定的患者中有 58%为男性。诊断时的中位年龄范围为 65 至 69 岁。本系列中最常见的组织学亚型是弥漫性大 B 细胞淋巴瘤,占所有患者的 56%。该组的 5 年总生存率为 45%。多变量分析表明,诊断时年龄大于 60 岁、种族为“其他”(与“白人”相比)以及婚姻状况为单身或丧偶与全因死亡率增加相关(P<0.05)。
这是发表的最大系列 PPL 患者。年龄大于 60 岁、女性和已婚的婚姻状况被确定为预测全因死亡率降低的独立预后因素。